News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,620 Results
Type
Article (87351)
Company Profile (759)
Press Release (771485)
Multimedia
Podcasts (168)
Webinars (27)
Section
Business (233021)
Career Advice (4137)
Deals (39786)
Drug Delivery (134)
Drug Development (91232)
Employer Resources (202)
FDA (18270)
Job Trends (17394)
News (397312)
Policy (39918)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (141)
Alzheimer's disease (1669)
Antibody-drug conjugate (ADC) (219)
Approvals (18276)
Artificial intelligence (474)
Autoimmune disease (64)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (50)
Breast cancer (468)
Cancer (3729)
Cardiovascular disease (330)
Career advice (3552)
Career pathing (37)
CAR-T (237)
CDC (53)
Cell therapy (655)
Cervical cancer (32)
Clinical research (75174)
Collaboration (1342)
Company closure (4)
Compensation (915)
Complete response letters (59)
COVID-19 (2947)
CRISPR (80)
C-suite (553)
Cystic fibrosis (132)
Data (4099)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (443)
Diagnostics (7075)
Digital health (35)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (178)
Drug shortages (36)
Duchenne muscular dystrophy (195)
Earnings (98697)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132653)
Executive appointments (972)
FDA (20631)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1204)
Gene editing (168)
Generative AI (45)
Gene therapy (520)
GLP-1 (1007)
Government (5371)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (36)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3177)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (180)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (31)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (532)
Lymphoma (256)
Machine learning (27)
Management (66)
Manufacturing (610)
MASH (130)
Medical device (14852)
Medtech (14873)
Mergers & acquisitions (22713)
Metabolic disorders (1125)
Multiple sclerosis (133)
NASH (23)
Neurodegenerative disease (216)
Neuropsychiatric disorders (59)
Neuroscience (2659)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (56)
Obesity (551)
Opinion (308)
Ovarian cancer (122)
Pain (160)
Pancreatic cancer (163)
Parkinson's disease (232)
Partnered (28)
Patents (402)
Patient recruitment (295)
Peanut (57)
People (66171)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23172)
Phase II (32645)
Phase III (24562)
Pipeline (2600)
Policy (288)
Postmarket research (3554)
Preclinical (10461)
Press Release (72)
Prostate cancer (187)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (644)
Real estate (7420)
Recruiting (78)
Regulatory (27883)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (69)
Schizophrenia (129)
Series A (200)
Series B (148)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (89)
The Weekly (106)
Vaccines (1027)
Venture capital (66)
Weight loss (387)
Women's health (57)
Worklife (21)
Date
Today (108)
Last 7 days (614)
Last 30 days (2292)
Last 365 days (33644)
2025 (25159)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50879)
Australia (8939)
California (9182)
Canada (2794)
China (863)
Colorado (391)
Connecticut (410)
Delaware (253)
Europe (116913)
Florida (1350)
Georgia (308)
Hawaii (3)
Idaho (67)
Illinois (800)
India (47)
Indiana (447)
Iowa (19)
Japan (299)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1244)
Massachusetts (6920)
Michigan (307)
Minnesota (552)
Mississippi (4)
Missouri (115)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2545)
New Mexico (32)
New York (2509)
North Carolina (1388)
North Dakota (10)
Northern California (4110)
Ohio (286)
Oklahoma (20)
Oregon (50)
Pennsylvania (1918)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3509)
Tennessee (148)
Texas (1438)
United States (34046)
Utah (272)
Virginia (243)
Washington D.C. (82)
Washington State (792)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,620 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
CDC
CDC Adopts ACIP Recommendations on Chickenpox, COVID-19 Vaccines
A new group of CDC advisors voted last month to separate the chickenpox vaccine from the measles, mumps, rubella components of the MMRV shot due to concerns over febrile seizures, while recommending a more risk-based approach to COVID-19 immunizations that mirrors recent FDA approvals.
October 6, 2025
·
1 min read
·
Heather McKenzie
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
The hold was placed earlier this year when the FDA asked for more preclinical data, but the agency was slow to respond due to ‘strain’ on its capacity, according to Neurizon.
October 6, 2025
·
2 min read
·
Dan Samorodnitsky
Layoff Tracker
Mythic Cuts Staff While Sharpening Focus on Lead Candidate
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
October 6, 2025
·
215 min read
·
BioSpace Editorial Staff
Press Releases
BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial Study of ML-016 in Advanced Cancers with Lung and/or Liver Involvement
October 6, 2025
·
1 min read
Press Releases
Optimi Health’s Psilocybin Capsules Selected for Medibank Insurance Program
Australia’s largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSD
October 6, 2025
·
5 min read
Press Releases
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
October 6, 2025
·
3 min read
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
AstraZeneca has invested heavily in AI, primarily through collaborations, including an up to $5.3 billion partnership with China’s CSPC Pharmaceutical in June.
October 6, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S.
October 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer
October 6, 2025
·
8 min read
Press Releases
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
October 6, 2025
·
6 min read
1 of 85,962
Next
